Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock.
Hernandez GA, Lemor A, Blumer V, Rueda CA, Zalawadiya S, Stevenson LW, Lindenfeld J. Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock.. Journal of cardiac failure 2019; .
Journal of cardiac failure
BACKGROUND: The pulmonary artery catheter (PAC) has been used in a wide-range of critically ill patients. It is not indicated for routine care of heart failure (HF) but its role in cardiogenic shock (CS) has not been clarified. METHODS AND RESULTS: We conducted a retrospective cohort study using the National Inpatient Sample and identified a total of 9,431,944 adult patients between 2004 and 2014 admitted with the primary diagnosis of HF (n=8,516,528) or who developed CS (n= 915,416) during the index hospitalization. Overall, patients with PAC had increased hospital costs, length of stay and mechanical circulatory support use. In patients with HF, PAC use was associated with higher mortality (9.9% vs. 3.3% OR 3.96 p<0.001) but the excess mortality declined over time. In those with CS, PAC was associated with lower mortality (35.1% vs. 39.2% OR 0.91 p<0.001) and in-hospital cardiac arrest (14.9% vs 18.3% OR 0.77 p<0.001); this paradox persisted after propensity score matching. CONCLUSION: The use of PAC in CS has decreased from 2004 to 2014, however its use is now associated with improved outcomes, which may reflect better selection of patients or better use of the information to guide therapies. Our data provides reassurance that PAC use in this population is an appropriate strategy.
ePub ahead of print